SEC Form 4 · accession 0001140361-18-003088
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Hunt
Officer — Chief Executive Officer · Director
Period of report
Jan 22, 2018
Accepted (ET)
Jan 24, 2018 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 22, 2018 | S | 8,970 | $35.947 | D | 83,613 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 17, 2017.
- F2$35.947 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.58 to $36.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.